We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01803581
Recruitment Status : Unknown
Verified March 2013 by Oystershell NV.
Recruitment status was:  Enrolling by invitation
First Posted : March 4, 2013
Last Update Posted : March 4, 2013
Sponsor:
Information provided by (Responsible Party):
Oystershell NV

Brief Summary:
The purpose of this study is to compare the efficacy and safety of an insecticide-free head lice product with that of a pyrethrum-based product.

Condition or disease Intervention/treatment Phase
Head Lice Other: X92001327 Other: RID shampoo Phase 3

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: A Randomized, Controlled, Investigator-blinded, Comparative Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
Study Start Date : February 2013
Estimated Primary Completion Date : May 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lice
U.S. FDA Resources

Arm Intervention/treatment
Experimental: X92001327
the X92001327 product is a lotion to be applied on dry hair for 15 minutes and then washed out using shampoo. The product is to be applied on Day 0 and repeated again on Day 7.
Other: X92001327
Active Comparator: RID shampoo
The RID shampoo is to be applied on dry the hair for 10 minutes and then rinsed out with water. the product is to be applied on Day 0 and repeated again on Day 7.
Other: RID shampoo



Primary Outcome Measures :
  1. proportion of subjects lice free at the end of the study (Day 10) [ Time Frame: Day 10 ]

Secondary Outcome Measures :
  1. the proportion of subjects lice free at each of the intermediate evaluations (Day 1, Day 7) [ Time Frame: Day 1, Day 7 ]

Other Outcome Measures:
  1. eye irritation [ Time Frame: Day1, Day7, Day10 ]
  2. scalp condition [ Time Frame: Day0, Day1, Day7, Day10 ]
  3. Adverse events collection [ Time Frame: Day1, Day7, Day10 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male or female over the age of 1 at the time of signing the informed consent or giving assent
  • Have an active head lice infestation of at least 5 live lice and 5 viable nits
  • subject must be capable of understanding and providing written informed consent
  • agree not to use any other pediculicides or medicated hair grooming products for the duration of the study
  • agree not to use a lice comb during the study
  • the parent or guardian of a child must be willing to have other family members screened for head lice.
  • have a single place of residence

Exclusion Criteria:

  • used any form of head lice treatment whether prescription or over the counter or home remedy at least four weeks prior to their screening visit
  • used any topical medication of any kind for a period of 48 hours prior to the screening visit
  • individuals on systemic or topical drugs or medications, including systemic antibiotics, which in the opinion of the investigative personnel may interfere with the study results
  • has a history of allergy or hypersensitivity to ragweed, hydrocarbons, sesame oil, perfume or any ingredient in either test product
  • individuals with any visible skin/scalp condition at the treatment site which, in the opinion of the investigative personnel will interfere with the evaluation of the test product
  • individuals who, in the opinion of the investigative personnel do not understand the subject requirements for study participation and/or may be likely to exhibit poor compliance with the required visits
  • females who are pregnant or nursing
  • patients that have taken trimethoprim or a combination of sulfamethoxazole at evaluation or during the previous 4 weeks
  • subjects with hair longer than mid back

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01803581


Locations
United States, Florida
Lice Source services Inc
Plantation, Florida, United States, 33313
Sponsors and Collaborators
Oystershell NV
Investigators
Principal Investigator: Lidia Serrano Lice Source Services

Publications:
Responsible Party: Oystershell NV
ClinicalTrials.gov Identifier: NCT01803581     History of Changes
Other Study ID Numbers: OYS004-0013
First Posted: March 4, 2013    Key Record Dates
Last Update Posted: March 4, 2013
Last Verified: March 2013

Additional relevant MeSH terms:
Lice Infestations
Ectoparasitic Infestations
Skin Diseases, Parasitic
Parasitic Diseases
Skin Diseases, Infectious
Skin Diseases